1
Clinical Trials associated with V3-MyomaOpen Label Phase II Clinical Trial of Myoma Immunotherapy
Myoma of the uterus or uterine fibroids are benign tumors that appears in the myometrium or the muscular layer of the uterus. It is one of the most common diseases in pre-climax women, reaching 12-25% of all gynecological diseases. There is an opinion that the true prevalence of myoma is much larger and reaches up to 80%, i.e., practically every second woman has it, often without knowing about. For the treatment of MM, surgical removal of the nodes or removal of the uterus is used. In addition, GnRH-agonist therapy is practiced, as well as embolization to block blood flow in the tumor. We propose to evaluate the immunotherapy approach in an open label Phase II study in 20 women with myoma, for whom no alternative therapy is available.
100 Clinical Results associated with V3-Myoma
100 Translational Medicine associated with V3-Myoma
100 Patents (Medical) associated with V3-Myoma
100 Deals associated with V3-Myoma